COMPANY NEWS
August 15, 2024
June 30, 2024
Novel p62-based treatment accelerates wound healing and reduces complications
June 14, 2024
University of Camerino and CureLab Oncology announce strategic partnership to turn recent discovery into next-generation medicine
March 25, 2024
This latest patent registration provides a pathway to commercial agreements in Canada with high economic potential for CureLab Oncology; separately, CureLab Oncology has provided exclusive licensing rights to its sister company, CureLab Veterinary, for use with dogs, cats and horses
March 20, 2024
Researchers say their ability to create Elenagen was only possible because of their opposition to dominant biotech doctrine